Haverford Financial Services, Inc. Merck & Co., Inc. Transaction History

Haverford Financial Services, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 10, 2020	SELL	$73.18 - $82.95 $216,685 - $245,614	-2,961 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $208,513 - $237,264	2,961 New	2,961 $229,000
Q4 2018 Feb 12, 2019	SELL	$65.24 - $75.71 $210,659 - $244,467	-3,229 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$57.69 - $67.84 $186,281 - $219,055	3,229 New	3,229 $229,000
Q2 2018 Aug 10, 2018	SELL	$50.83 - $59.72 $228,023 - $267,903	-4,486 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$50.96 - $59.23 $107,627 - $125,093	-2,112 Reduced 32.01%	4,486 $244,000
Q4 2017 Feb 13, 2018	SELL	$51.62 - $61.64 $9,446 - $11,280	-183 Reduced 2.7%	6,598 $371,000
Q3 2017 Nov 09, 2017	BUY	$58.67 - $63.13 $58 - $63	1 Added 0.01%	6,781 $434,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,780	6,780 $435,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Haverford Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Haverford Financial Services, Inc. with notifications on news.